Nxstage Medicine (NXTM) is the Chart of the Day. The medical device company had 18 new highs and gained 27.32% in the last month. The stock rates both a Trend spotter buy signal and 96% technical buy signals.
Article:
The Chart of the Day is Nxstage Medicine (NXTM) with both a Trend Spotter buy signal and 96% technical buy signals. The Relative Strength Index of 79.94% was earned by having 18 new highs and a gain of 27.72% in the last month. The stock was discovered on the New High List.
The company is a medical device company that develops, manufactures and markets systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure.
Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.
Barchart technical indicators:
- 96% Barchart technical buy signals
- Trend spotter buy signals
- Above its 20, 50 and 100 day moving averages
- 18 new highs and up 27.72% in the last month
- Relative Strength Index 79.94%
- Barchart computes a technical support level at 13.35
- Recently traded at 13.87 with a 50 day moving average of 11.66
Fundamental factors:
- Market Cap $823.18 million
- Revenue projected to increase 9.00% this year and 11.90% next year
- Earnings estimated to grow 53.80% next year and continue to grow by 20.50% annually for the next 5 years
- Wall Street analysts issued 5 strong buy, 1 buy and 3 hold recommendations
- Financial Strength B+
Exit if the stock drops below its 50 day moving average.
No comments:
Post a Comment